These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21789170)

  • 21. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
    Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
    Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate.
    Xu LL; Shanmugam N; Segawa T; Sesterhenn IA; McLeod DG; Moul JW; Srivastava S
    Genomics; 2000 Jun; 66(3):257-63. PubMed ID: 10873380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis.
    Wang XD; Wang BE; Soriano R; Zha J; Zhang Z; Modrusan Z; Cunha GR; Gao WQ
    Differentiation; 2007 Mar; 75(3):219-34. PubMed ID: 17288544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
    Shiota M; Yokomizo A; Naito S
    Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
    Swinnen JV; Esquenet M; Heyns W; Rombauts W; Verhoeven G
    Mol Cell Endocrinol; 1994 Sep; 104(2):153-62. PubMed ID: 7527352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer.
    Pelzer AE; Bektic J; Haag P; Berger AP; Pycha A; Schäfer G; Rogatsch H; Horninger W; Bartsch G; Klocker H
    J Urol; 2006 Apr; 175(4):1517-22. PubMed ID: 16516039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer.
    Gonthier K; Poluri RTK; Audet-Walsh É
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105367. PubMed ID: 31051242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications.
    Mostaghel EA; Nelson PS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):243-58. PubMed ID: 18471783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.
    Wang Z; Wang Z; Guo J; Li Y; Bavarva JH; Qian C; Brahimi-Horn MC; Tan D; Liu W
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3053-8. PubMed ID: 22315407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential proteome expression analysis of androgen-dependent and -independent pathways in LNCaP prostate cancer cells.
    Cha S; Shin DH; Seok JR; Myung JK
    Exp Cell Res; 2017 Oct; 359(1):215-225. PubMed ID: 28736082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis.
    Tousignant KD; Rockstroh A; Taherian Fard A; Lehman ML; Wang C; McPherson SJ; Philp LK; Bartonicek N; Dinger ME; Nelson CC; Sadowski MC
    Mol Cancer Res; 2019 May; 17(5):1166-1179. PubMed ID: 30808729
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular regulation of androgen action in prostate cancer.
    Dehm SM; Tindall DJ
    J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independence of HIF1a and androgen signaling pathways in prostate cancer.
    Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
    BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic signatures of angiogenesis in androgen-independent prostate cancer.
    Karagiannis GS; Saraon P; Jarvi KA; Diamandis EP
    Prostate; 2014 Feb; 74(3):260-72. PubMed ID: 24166580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.
    Begemann D; Anastos H; Kyprianou N
    Int J Urol; 2018 Apr; 25(4):318-326. PubMed ID: 29345000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a castrate resistant transplant tumor model of prostate cancer.
    Ellis L; Lehet K; Ramakrishnan S; Adelaiye R; Pili R
    Prostate; 2012 May; 72(6):587-91. PubMed ID: 21796655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.
    Locke JA; Guns ES; Lubik AA; Adomat HH; Hendy SC; Wood CA; Ettinger SL; Gleave ME; Nelson CC
    Cancer Res; 2008 Aug; 68(15):6407-15. PubMed ID: 18676866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases.
    Vellaichamy A; Sreekumar A; Strahler JR; Rajendiran T; Yu J; Varambally S; Li Y; Omenn GS; Chinnaiyan AM; Nesvizhskii AI
    PLoS One; 2009 Sep; 4(9):e7075. PubMed ID: 19763266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsies.
    Morse N; Jamaspishvili T; Simon D; Patel PG; Ren KYM; Wang J; Oleschuk R; Kaufmann M; Gooding RJ; Berman DM
    Lab Invest; 2019 Oct; 99(10):1561-1571. PubMed ID: 31160688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.